T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
EOG Resources
EOG
$74.6B
| $399M | 0.08% |
4,338,812
+1,547,453
| +55% | +$144M |
|
|
WWAV
277
DELISTED
The WhiteWave Foods Company
WWAV
| $399M | 0.08% |
11,390,610
-795,701
| -7% | -$28.2M |
|
278
Cardinal Health
CAH
$55.1B
| $398M | 0.08% |
4,936,148
-5,566,378
| -53% | -$440M |
|
|
AVNR
279
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $398M | 0.08% |
23,465,722
-4,581,500
| -16% | -$64.5M |
|
280
Fastenal
FAST
$60B
| $393M | 0.08% |
33,010,904
-3,615,304
| -10% | -$40.5M |
|
281
Enovis
ENOV
$1.39B
| $390M | 0.08% |
4,395,987
+1,439,950
| +49% | +$130M |
|
282
Pacira BioSciences
PCRX
$968M
| $388M | 0.08% |
4,377,651
-752,614
| -15% | -$71.2M |
|
|
RAX
283
DELISTED
Rackspace Hosting Inc
RAX
| $387M | 0.08% |
8,269,527
-220,852
| -3% | -$9.1M |
|
284
BWX Technologies
BWXT
$15.6B
| $386M | 0.08% |
17,822,874
-5,983,142
| -25% | -$125M |
|
285
Public Storage
PSA
$60.7B
| $385M | 0.08% |
2,081,308
-22,946
| -1% | -$4.15M |
|
286
Allstate
ALL
$65.1B
| $384M | 0.08% |
5,459,656
-464,666
| -8% | -$30.6M |
|
287
LPL Financial
LPLA
$29.4B
| $379M | 0.08% |
8,515,217
+668,909
| +9% | +$28.8M |
|
288
Allegiant Air
ALGT
$2.36B
| $378M | 0.08% |
2,514,434
-193,515
| -7% | -$25.4M |
|
289
Stryker
SYK
$133B
| $378M | 0.08% |
4,004,562
-448,134
| -10% | -$39.8M |
|
290
Dollar General
DG
$26.4B
| $376M | 0.08% |
5,314,260
+277,710
| +6% | +$18.1M |
|
|
THS
291
DELISTED
Treehouse Foods
THS
| $374M | 0.08% |
4,371,043
-368,040
| -8% | -$30.5M |
|
|
CLGX
292
DELISTED
Corelogic, Inc.
CLGX
| $372M | 0.08% |
11,783,911
-488,880
| -4% | -$14.9M |
|
|
ARG
293
DELISTED
Airgas Inc
ARG
| $369M | 0.08% |
3,203,656
-173,558
| -5% | -$19.5M |
|
294
Ingredion
INGR
$6.55B
| $364M | 0.08% |
4,296,018
+984,999
| +30% | +$78.3M |
|
295
Palo Alto Networks
PANW
$312B
| $364M | 0.08% |
17,820,780
+14,485,482
| +434% | +$267M |
|
296
Pediatrix Medical
MD
$2.14B
| $364M | 0.08% |
5,500,596
+14,020
| +0.3% | +$856K |
|
297
First American
FAF
$7.4B
| $363M | 0.08% |
10,721,591
+18,306
| +0.2% | +$561K |
|
298
Prologis
PLD
$133B
| $362M | 0.08% |
8,418,652
-3,420
| -0% | -$140K |
|
299
Under Armour
UAA
$2.27B
| $362M | 0.08% |
10,650,752
-61,216
| -0.6% | -$2.06M |
|
300
Trimble
TRMB
$13.4B
| $358M | 0.08% |
13,504,406
+2,862,007
| +27% | +$80.7M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.